GNPX — Genprex, Inc.
Healthcare • Biotechnology
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and...…
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $3.35
- Day High
- $3.54
- Day Low
- $3.22
- 52w High
- $63.00
- 52w Low
- $2.61
- Volume
- 300,800
- Avg Volume
- Beta
- -0.759
* TTM/most recent where available
Company
- Ticker
- GNPX
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Ryan Confer
- Employees
- 15
- Website
- www.genprex.com
Key Metrics
- Market Cap
- 5.48M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).